Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Bladder Cancer

  Free Subscription


Articles published in Int J Oncol

Retrieve available abstracts of 8 articles:
HTML format



Single Articles


    May 2024
  1. XU M, Gu M, Zhou J, Da J, et al
    [Retracted] Interaction of YAP1 and mTOR promotes bladder cancer progression.
    Int J Oncol. 2024;64:50.
    PubMed     Abstract available


    December 2023
  2. WANG Z, Li L, Chu C, Wei X, et al
    CUDC?101 is a potential target inhibitor for the EGFR?overexpression bladder cancer cells.
    Int J Oncol. 2023;63:131.
    PubMed     Abstract available


    July 2023
  3. LI Z, Jiang Y, Liu J, Fu H, et al
    Exosomes from PYCR1 knockdown bone marrow mesenchymal stem inhibits aerobic glycolysis and the growth of bladder cancer cells via regulation of the EGFR/PI3K/AKT pathway.
    Int J Oncol. 2023;63:84.
    PubMed     Abstract available


    June 2023
  4. ZHANG S, Zhang C, Liu W, Zheng W, et al
    [Retracted] MicroRNA‑24 upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3.
    Int J Oncol. 2023;62:67.
    PubMed     Abstract available


    May 2023
  5. HWANG TI, Cuiu YC, Chen YC, Chen PC, et al
    Tumor suppressive functions of hsa‑miR‑34a on cell cycle, migration and protective autophagy in bladder cancer.
    Int J Oncol. 2023;62:66.
    PubMed     Abstract available


    July 2021
  6. KIM CJ, Terado T, Tambe Y, Mukaisho KI, et al
    Cryptotanshinone, a novel PDK 4 inhibitor, suppresses bladder cancer cell invasiveness via the mTOR/betacatenin/Ncadherin axis.
    Int J Oncol. 2021;59.
    PubMed     Abstract available


  7. PIAO XM, Hwang B, Jeong P, Byun YJ, et al
    Collagen type VIalpha1 and 2 repress the proliferation, migration and invasion of bladder cancer cells.
    Int J Oncol. 2021;59.
    PubMed     Abstract available


    December 2020
  8. BIAN J, Li B, Zeng X, Hu H, et al
    [Corrigendum] Mutation of TGFbeta receptor II facilitates human bladder cancer progression through altered TGFbeta1 signaling pathway.
    Int J Oncol. 2020 Dec 14. doi: 10.3892/ijo.2020.5161.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.